Endocrinology and Metabolism

Min Jung Jung (Jung MJ)

2 Articles

Thyroid
Response: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab 2014;29:536-44, Min Jung Jung et al.): Min Jung Jung, Su Kyoung Kwon; Endocrinol Metab. 2015;30(2):233-234. Published online June 30, 2015; DOI: https://doi.org/10.3803/EnM.2015.30.2.233

2,909 View
30 Download

PDF PubReader

Thyroid
Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance: Min Jung Jung, Su Kyoung Kwon; Endocrinol Metab. 2014;29(4):536-544. Published online December 29, 2014; DOI: https://doi.org/10.3803/EnM.2014.29.4.536

4,071 View
51 Download
18 Web of Science
18 Crossref

Abstract PDF PubReader

Background

Incretin-based therapies are rapidly becoming one of the main glycemic control strategies in diabetes. Considering the large numbers of papillary thyroid carcinomas (PTCs) and possible effects of glucagon-like peptide-1 (GLP-1) on cell proliferation, the expression of GLP-1 receptor (GLP-1R) in PTC is likely to have clinical significance. We performed this study to evaluate the expression of GLP-1R in PTC and the clinical meaning of GLP-1R expression in PTC.

Methods

Fifty-six cases of PTC, four cases of medullary thyroid cancer (MTC), seven cases of nodular hyperplasia and 56 normal thyroid tissue samples were selected for immunostaining for GLP-1R. Clinical parameters were obtained by retrospective review of medical records.

Results

Immunohistochemical staining for GLP-1R showed immunoreactivity in 18 of 56 cases of PTC (32.1%). All four cases of MTC exhibited cytoplasmic GLP-1R expression. Nodular hyperplasia exhibited immunoreactivity in two of seven cases (28.6%). All normal thyroid follicular cells showed negative immunoreactivity. In univariable and multivariable analyses, tumor multifocality was negatively correlated with GLP-1R expression. Extrathyroidal extension showed positive association with GLP-1R expression that was almost significant. Sex, age, tumor size, and lymph node metastasis were not significantly associated with GLP-1R expression.

Conclusion

Some parts of PTC tissues express GLP-1R, and GLP-1R expression in PTC was negatively correlated with tumor multifocality. The long-term influence of pharmacologically increased GLP-1 on thyroid follicular cells and development and progression of tumors originating from thyroid follicular cells should be investigated.

Citations

Citations to this article as recorded by

Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study
Sungho Bea, Heejun Son, Jae Hyun Bae, Sun Wook Cho, Ju‐Young Shin, Young Min Cho
Diabetes, Obesity and Metabolism.2024; 26(1): 108. CrossRef
Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials
Giovanni Antonio Silverii, Matteo Monami, Marco Gallo, Alberto Ragni, Francesco Prattichizzo, Valerio Renzelli, Antonio Ceriello, Edoardo Mannucci
Diabetes, Obesity and Metabolism.2024; 26(3): 891. CrossRef
Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review
Ana E. Espinosa De Ycaza, Juan P. Brito, Rozalina G. McCoy, Hui Shao, Naykky Singh Ospina
Thyroid®.2024;[Epub] CrossRef
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels
Stefania Capuccio, Sabrina Scilletta, Francesca La Rocca, Nicoletta Miano, Maurizio Di Marco, Giosiana Bosco, Francesco Di Giacomo Barbagallo, Roberto Scicali, Salvatore Piro, Antonino Di Pino
Biomolecules.2024; 14(6): 687. CrossRef
Investigation the impact of liraglutide on the thyroid function tests
Emre URHAN
Turkish Journal of Clinics and Laboratory.2023; 14(2): 339. CrossRef
GLP-1R polymorphism (rs1042044) and expression are associated with the risk of papillary thyroid cancer among the Egyptian population
Rehab S. Abdul-Maksoud, Walid S.H. Elsayed, Nearmeen M. Rashad, Rasha S. Elsayed, Shereen Elshorbagy, Mohamed G. Hamed
Gene.2022; 834: 146597. CrossRef
Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials
Weiting Hu, Rui Song, Rui Cheng, Caihong Liu, Rui Guo, Wei Tang, Jie Zhang, Qian Zhao, Xing Li, Jing Liu
Frontiers in Endocrinology.2022;[Epub] CrossRef
GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS
Zheng Yang, Yuhuan Lv, Meng Yu, Mei Mei, Linyu Xiang, Subei Zhao, Rong Li
Frontiers in Pharmacology.2022;[Epub] CrossRef
The Effect of Exenatide on Thyroid-Stimulating Hormone and Thyroid Volume
Muhammed Erkam Sencar, Davut Sakiz, Murat Calapkulu, Sema Hepsen, Muhammed Kizilgul, Ilknur Unsal Ozturk, Bekir Ucan, Murat Bayram, Busra Betul Cagir, Safak Akin, Mustafa Ozbek, Erman Cakal
European Thyroid Journal.2019; 8(6): 307. CrossRef
Expression of GLP-1 receptor and CD26 in human thyroid C-cells: The association of thyroid C-cell tumorigenesis with incretin-based medicine
Yuejia Song, Min Zhou, Yang Cao, Jiping Qi, Jingshu Geng, Xiaomin Liu
Oncology Letters.2017; 13(4): 2684. CrossRef
Exendin-4 does not modify growth or apoptosis of human colon cancer cells
He Wenjing, Yu Shuang, Li Weisong, Xiao Haipeng
Endocrine Research.2017; : 1. CrossRef
GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control
Takashi Nomiyama, Toshihiko Yanase
Expert Review of Endocrinology & Metabolism.2016; : 1. CrossRef
Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells
Wenjing He, Shuang Yu, Liantang Wang, Mian He, Xiaopei Cao, Yanbing Li, Haipeng Xiao
Molecular and Cellular Endocrinology.2016; 436: 240. CrossRef
Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma
Sebastian Bardosi, Attila Bardosi, Zsuzsanna Nagy, Dora Reglodi
Journal of Molecular Neuroscience.2016; 60(2): 171. CrossRef
Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes
Chin-Hsiao Tseng
Oncotarget.2016; 7(17): 24871. CrossRef
Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47. CrossRef
Response: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab2014;29:536-44, Min Jung Jung et al.)
Min Jung Jung, Su Kyoung Kwon
Endocrinology and Metabolism.2015; 30(2): 233. CrossRef
Letter: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab2014;29:536-44, Min Jung Jung et al.)
Daeyoon Park, Eun Kyung Lee
Endocrinology and Metabolism.2015; 30(2): 231. CrossRef

Author index